Status:
UNKNOWN
The Role Of FGF23, Klotho, And Sclerostin In Kidney Stone Formers
Lead Sponsor:
University of Zurich
Conditions:
Kidney Stones
Eligibility:
All Genders
18-70 years
Brief Summary
Kidney stones are very common in industrialized countries and the lifetime risk is about 10 to 15% in this population. Kidney stones are composed of inorganic and organic components. Calcium containin...
Detailed Description
Kidney stones are very common in industrialized countries and the lifetime risk is about 10 to 15% in this population. Men are more affected than women and the mean age of the patients is be-tween the...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- \- stoneformer patients with signed informed consent
Exclusion
Key Trial Info
Start Date :
January 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2014
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT01526304
Start Date
January 1 2012
End Date
January 1 2014
Last Update
February 3 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Zurich, Nephrology
Zurich, Canton of Zurich, Switzerland, 8091